Théodore ARNAUD is completing his PhD both at Cermav and the Laue-Langevin Institute (ILL), under the co-supervision of Anne Imberty, CNRS Research Director, and Matthew Blakeley, Scientist and LADI/DALI Instrument Manager, respectively.
Théodore ARNAUD ‘s work focuses on neutron diffraction to decipher the interaction of pathogens with human glycolipids.
This work is financially supported by the Université Grenoble Alpes through its IRGA (Research Initiatives in Grenoble Alpes) call for projects.
Find a profile of Théodore ARNAUD on the Université Grenoble Alpes website:
